Ngoc Duc Doan - Publications

Affiliations: 
2014- Chemistry Massachusetts Institute of Technology, Cambridge, MA, United States 

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Traoré M, Gignac M, Doan ND, Hof F, Lubell WD. Aza-amino acid scanning of chromobox homolog 7 (CBX7) ligands. Journal of Peptide Science : An Official Publication of the European Peptide Society. PMID 28220557 DOI: 10.1002/psc.2982  0.96
2017 Nadeau-Vallée M, Chin PY, Belarbi L, Brien MÈ, Pundir S, Berryer MH, Beaudry-Richard A, Madaan A, Sharkey DJ, Lupien-Meilleur A, Hou X, Quiniou C, Beaulac A, Boufaied I, Boudreault A, ... ... Doan ND, et al. Antenatal Suppression of IL-1 Protects against Inflammation-Induced Fetal Injury and Improves Neonatal and Developmental Outcomes in Mice. Journal of Immunology (Baltimore, Md. : 1950). PMID 28148737 DOI: 10.4049/jimmunol.1601600  0.96
2016 DiChiara AS, Taylor RJ, Wong MY, Doan ND, Del Rosario AM, Shoulders MD. Mapping and Exploring the Collagen-I Proteostasis Network. Acs Chemical Biology. PMID 26848503 DOI: 10.1021/acschembio.5b01083  0.8
2015 Doan ND, Poujol de Molliens M, Létourneau M, Fournier A, Chatenet D. Optimization of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for peptides and its use in a structure-activity relationship study of a class B GPCR ligand. European Journal of Medicinal Chemistry. 104: 106-14. PMID 26448038 DOI: 10.1016/j.ejmech.2015.09.017  0.84
2015 Lamine A, Létourneau M, Doan ND, Maucotel J, Couvineau A, Vaudry H, Chatenet D, Vaudry D, Fournier A. Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model. Neuropharmacology. PMID 26006268 DOI: 10.1016/j.neuropharm.2015.05.014  0.84
2015 Doan ND, Lubell WD. X-ray structure analysis reveals β-turn mimicry by N-amino-imidazolidin-2-ones. Biopolymers. 104: 629-35. PMID 25787802 DOI: 10.1002/bip.22646  0.96
2015 Doan ND, Zhang J, Traoré M, Kamdem W, Lubell WD. Solid-phase synthesis of C-terminal azapeptides. Journal of Peptide Science : An Official Publication of the European Peptide Society. 21: 387-91. PMID 25400083 DOI: 10.1002/psc.2711  0.96
2014 Traoré M, Doan ND, Lubell WD. Diversity-oriented synthesis of azapeptides with basic amino acid residues: aza-lysine, aza-ornithine, and aza-arginine. Organic Letters. 16: 3588-91. PMID 24959890 DOI: 10.1021/ol501586y  0.96
2014 Le XT, Doan ND, Dequivre T, Viel P, Palacin S. Covalent grafting of chitosan onto stainless steel through aryldiazonium self-adhesive layers. Acs Applied Materials & Interfaces. 6: 9085-92. PMID 24870015 DOI: 10.1021/am500582e  0.96
2014 Doan ND, Hopewell R, Lubell WD. N-aminoimidazolidin-2-one peptidomimetics. Organic Letters. 16: 2232-5. PMID 24697286 DOI: 10.1021/ol500739k  0.96
2013 Chatenet D, Létourneau M, Nguyen QT, Doan ND, Dupuis J, Fournier A. Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation. British Journal of Pharmacology. 168: 807-21. PMID 22994258 DOI: 10.1111/j.1476-5381.2012.02217.x  0.84
2012 Doan ND, Létourneau M, Vaudry D, Doucet N, Folch B, Vaudry H, Fournier A, Chatenet D. Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 256-65. PMID 22922050 DOI: 10.1016/j.jconrel.2012.08.021  0.84
2012 Doan ND, Chatenet D, Létourneau M, Vaudry H, Vaudry D, Fournier A. Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Biochimica Et Biophysica Acta. 1823: 940-9. PMID 22343001 DOI: 10.1016/j.bbamcr.2012.02.001  0.84
2012 Doan ND, Nguyen TT, Létourneau M, Turcotte K, Fournier A, Chatenet D. Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart. British Journal of Pharmacology. 166: 243-57. PMID 22044114 DOI: 10.1111/j.1476-5381.2011.01710.x  0.84
2011 Bourgault S, Chatenet D, Wurtz O, Doan ND, Leprince J, Vaudry H, Fournier A, Vaudry D. Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug. Current Pharmaceutical Design. 17: 1002-24. PMID 21524253 DOI: 10.2174/138161211795589337  0.84
2011 Dejda A, Bourgault S, Doan ND, Létourneau M, Couvineau A, Vaudry H, Vaudry D, Fournier A. Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP. Biochimie. 93: 669-77. PMID 21185349 DOI: 10.1016/j.biochi.2010.12.010  0.84
2011 Doan ND, Bourgault S, Dejda A, Létourneau M, Detheux M, Vaudry D, Vaudry H, Chatenet D, Fournier A. Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochemical Pharmacology. 81: 552-61. PMID 21114961 DOI: 10.1016/j.bcp.2010.11.015  0.84
2009 Bourgault S, Vaudry D, Dejda A, Doan ND, Vaudry H, Fournier A. Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective Peptide. Current Medicinal Chemistry. 16: 4462-80. PMID 19835562 DOI: 10.2174/092986709789712899  0.84
2008 Doan ND, Bourgault S, Létourneau M, Fournier A. Effectiveness of the suzuki-miyaura cross-coupling reaction for solid-phase peptide modification. Journal of Combinatorial Chemistry. 10: 44-51. PMID 18067269 DOI: 10.1021/cc700128b  0.84
Show low-probability matches.